NLM Logo

osimertinib MeSH Supplementary Concept Data 2026


MeSH Supplementary
osimertinib
Unique ID
C000596361
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000596361
Entry Term(s)
2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-
AZD-9291
AZD-9291 mesylate
AZD9291
AZD9291 mesylate
N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide
N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1)
N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide
Tagrisso
mereletinib
mereletinib mesilate
mereletinib mesylate
osimertinib mesilate
osimertinib mesylate
Pharm Action
Antineoplastic Agents
Tyrosine Kinase Inhibitors
Registry Numbers
3C06JJ0Z2O
0
RDL94R2A16
Heading Mapped to
Acrylamides
Aniline Compounds
Indoles
Pyrimidines
Frequency
1081
Note
an EGFR tyrosine kinase inhibitor
Source
Cancer Discov. 2014 Aug;4(8):OF10.
Date Introduced
2015/03/29
Last Updated
2026/04/21
osimertinib Preferred
Tagrisso Narrower
AZD9291 Narrower
osimertinib mesylate Narrower
page delivered in 0.008s